<DOC>
	<DOCNO>NCT00105560</DOCNO>
	<brief_summary>RATIONALE : Specialized radiation therapy delivers radiation directly area tumor surgically remove may kill remain tumor cell cause less damage normal tissue . PURPOSE : This phase II trial study well proton beam radiation therapy work treat young patient undergone biopsy surgery medulloblastoma pineoblastoma .</brief_summary>
	<brief_title>Proton Beam Radiation Therapy Treating Young Patients Who Have Undergone Biopsy Surgery Medulloblastoma Pineoblastoma</brief_title>
	<detailed_description>OBJECTIVES : - Determine 3-year incidence severity ototoxicity young patient medulloblastoma pineoblastoma treat adjuvant proton beam craniospinal posterior fossa radiotherapy . - Determine incidence primary hypothyroidism endocrine dysfunction ( neuroendocrine end organ ) patient treat regimen . - Determine incidence severity neurocognitive abnormality patient treat regimen . - Determine acute side effect regimen , include esophagitis , upper low gastrointestinal tract disease , weight loss , patient . - Determine 3-year progression-free survival rate patient treat regimen . OUTLINE : Patients stratify accord risk ( standard vs high ) . Patients receive proton beam craniospinal posterior fossa radiotherapy daily 5 day week 6-8 weeks* . NOTE : *Unless otherwise specify co-existing protocol . Patients undergo neurocognitive evaluation baseline within 3 month completion radiotherapy 1 , 3 , 5 year . Patients also undergo endocrine evaluation baseline annually 5 year ; audiology evaluation baseline , course cisplatin-based chemotherapy ( receive ) , annually 5 year . After completion study treatment , patient follow every 3-6 month 2-5 year . PROJECTED ACCRUAL : A total 60 patient accrue study .</detailed_description>
	<mesh_term>Medulloblastoma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Pinealoma</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm medulloblastoma pineoblastoma Standardrisk highrisk disease Must undergone biopsy attempt surgical resection tumor within past 35 day Requires craniospinal irradiation PATIENT CHARACTERISTICS : Age 3 21 Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify Other Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy No 1 prior chemotherapy regimen No prior IV intrathecal methotrexate No prior intrathecal thiotepa Concurrent cisplatinbased chemotherapy , include chemotherapy administer another study , allow Endocrine therapy Not specify Radiotherapy No prior radiotherapy Surgery See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>long-term effect secondary cancer therapy child</keyword>
	<keyword>untreated childhood medulloblastoma</keyword>
	<keyword>untreated childhood pineoblastoma</keyword>
</DOC>